These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2715951)

  • 1. An intraoral drug delivery system.
    Seals RR; Aufdemorte TB; Cortes AL; Parel SM
    J Prosthet Dent; 1989 Feb; 61(2):239-42. PubMed ID: 2715951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical pearl: intraoral medication application using the "parked" cotton ball technique.
    Adams DR; Fulchiero GJ; Mutasim DF
    J Am Acad Dermatol; 2006 Dec; 55(6):1078-9. PubMed ID: 17110223
    [No Abstract]   [Full Text] [Related]  

  • 3. Gelclair oral gel.
    Buchsel PC
    Clin J Oncol Nurs; 2003; 7(1):109-10. PubMed ID: 12629946
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical cyclosporine for oral mucosal disorders.
    Eisen D; Ellis CN
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1259-63; discussion 1263-4. PubMed ID: 2277133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesiculo-erosive oral mucosal disease--management with topical corticosteroids: (1) Fundamental principles and specific agents available.
    González-Moles MA; Scully C
    J Dent Res; 2005 Apr; 84(4):294-301. PubMed ID: 15790732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of topical drugs in treatment of oral mucosal diseases. A literature review.
    Sheikh S; Gupta D; Pallagatti S; Singla I; Gupta R; Goel V
    N Y State Dent J; 2013 Nov; 79(6):58-64. PubMed ID: 24600767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and topical photodynamic therapy (PDT) on oral mucosa lesions: an overview.
    Di Stasio D; Romano A; Gentile C; Maio C; Lucchese A; Serpico R; Paparella R; Minervini G; Candotto V; Laino L
    J Biol Regul Homeost Agents; 2018; 32(2 Suppl. 1):123-126. PubMed ID: 29460529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological management of recurrent oral mucosal ulceration.
    Burgess JA; Johnson BD; Sommers E
    Drugs; 1990 Jan; 39(1):54-65. PubMed ID: 2178912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local drug delivery for oral mucosal diseases: challenges and opportunities.
    Sankar V; Hearnden V; Hull K; Juras DV; Greenberg MS; Kerr AR; Lockhart PB; Patton LL; Porter S; Thornhill M
    Oral Dis; 2011 Apr; 17 Suppl 1():73-84. PubMed ID: 21382140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ delivery of corticosteroids for treatment of oral diseases.
    Caro V; Sutera FM; Giannola LI
    Ther Deliv; 2017 Oct; 8(10):899-914. PubMed ID: 28944742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vesiculo-erosive oral mucosal disease--management with topical corticosteroids: (2) Protocols, monitoring of effects and adverse reactions, and the future.
    González-Moles MA; Scully C
    J Dent Res; 2005 Apr; 84(4):302-8. PubMed ID: 15790733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease.
    Wolff D; Anders V; Corio R; Horn T; Morison WL; Farmer E; Vogelsang GB
    Photodermatol Photoimmunol Photomed; 2004 Aug; 20(4):184-90. PubMed ID: 15238096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease.
    Epstein JB; Nantel S; Sheoltch SM
    Bone Marrow Transplant; 2000 Mar; 25(6):683-7. PubMed ID: 10734307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current situation and prospects of local therapy of oral mucosal diseases].
    Zheng JL
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Jun; 44(6):336-7. PubMed ID: 19953949
    [No Abstract]   [Full Text] [Related]  

  • 15. Bullous pemphigoid--management of a patient with oral and skin lesions.
    Ali TB; Zain RB; Adam BA
    Singapore Dent J; 1994 Jan; 19(1):18-21. PubMed ID: 9582679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents.
    Elad S; Epstein JB; von Bültzingslöwen I; Drucker S; Tzach R; Yarom N
    Expert Opin Emerg Drugs; 2011 Mar; 16(1):183-202. PubMed ID: 21244328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of topical administration of prostaglandin E2 on chemotherapy-associated oral mucosal lesions of the patients with hematological malignancies].
    Ueda E; Kitani T; Masaoka T; Horiuchi A; Yonezawa T
    Nihon Gan Chiryo Gakkai Shi; 1988 Mar; 23(3):752-8. PubMed ID: 3165420
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical corticosteroids and oral vesiculo-erosive disease: where's the beef???
    Kalmar JR
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Apr; 89(4):395-6. PubMed ID: 10760717
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical immunomodulators for management of oral mucosal conditions, a systematic review; part I: calcineurin inhibitors.
    Elad S; Epstein JB; Yarom N; Drucker S; Tzach R; von Bültzingslöwen I
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):713-26. PubMed ID: 21091397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of the topical application of triamcinolone on the healing oral mucous membranes wounds. Histologic study in rats (author's transl)].
    Langlois CC; Devildos LR
    Rev Bras Pesqui Med Biol; 1974; 7(4):373-81. PubMed ID: 4431985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.